QIAGEN NV's ticker is QGEN and the CUSIP is N72482123. A total of 213 filers reported holding QIAGEN NV in Q2 2017. The put-call ratio across all filers is 0.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $20,000 | -95.0% | 600 | -93.9% | 0.01% | -95.7% |
Q2 2019 | $397,000 | -8.5% | 9,800 | -9.3% | 0.12% | +98.3% |
Q1 2019 | $434,000 | +148.0% | 10,800 | +120.4% | 0.06% | +45.0% |
Q2 2018 | $175,000 | +29.6% | 4,900 | +16.7% | 0.04% | +21.2% |
Q1 2018 | $135,000 | -52.6% | 4,200 | -54.3% | 0.03% | -49.2% |
Q4 2017 | $285,000 | -35.5% | 9,200 | -34.4% | 0.06% | -33.7% |
Q3 2017 | $442,000 | -5.2% | 14,022 | +0.9% | 0.10% | +44.1% |
Q2 2017 | $466,000 | +1036.6% | 13,900 | +892.9% | 0.07% | +1260.0% |
Q1 2017 | $41,000 | – | 1,400 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
C M BIDWELL & ASSOCIATES LTD | 301,504 | $8,448,000 | 1.99% |
PRIMECAP MANAGEMENT CO/CA/ | 19,143,036 | $536,388,000 | 0.53% |
Granahan Investment Management | 535,700 | $15,010,000 | 0.52% |
FRONTIER CAPITAL MANAGEMENT CO LLC | 1,704,116 | $47,749,000 | 0.37% |
BALYASNY ASSET MANAGEMENT L.P. | 914,759 | $25,608,000 | 0.14% |
PARAMETRIC PORTFOLIO ASSOCIATES LLC | 626,250 | $17,548,000 | 0.02% |
BALYASNY ASSET MANAGEMENT L.P. | 153,700 | $4,303,000 | 0.02% |
Capital Research Global Investors | 2,259,565 | $63,393,000 | 0.02% |
RHUMBLINE ADVISERS | 201,388 | $5,643,000 | 0.01% |
TUDOR INVESTMENT CORP ET AL | 16,373 | $459,000 | 0.01% |